BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15511664)

  • 1. Chemoattractants and their receptors in homeostasis and inflammation.
    Sallusto F; Mackay CR
    Curr Opin Immunol; 2004 Dec; 16(6):724-31. PubMed ID: 15511664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
    Ebert LM; Schaerli P; Moser B
    Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking.
    Müller G; Lipp M
    Microcirculation; 2003 Jun; 10(3-4):325-34. PubMed ID: 12851649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding a way out: lymphocyte egress from lymphoid organs.
    Schwab SR; Cyster JG
    Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis.
    Zhang X; Nakajima T; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2005 Dec; 52(12):3839-49. PubMed ID: 16329093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics.
    Bromley SK; Thomas SY; Luster AD
    Nat Immunol; 2005 Sep; 6(9):895-901. PubMed ID: 16116469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
    Shiow LR; Rosen DB; Brdicková N; Xu Y; An J; Lanier LL; Cyster JG; Matloubian M
    Nature; 2006 Mar; 440(7083):540-4. PubMed ID: 16525420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease.
    Moschovakis GL; Förster R
    Eur J Immunol; 2012 Aug; 42(8):1949-55. PubMed ID: 22700449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia.
    Patrussi L; Capitani N; Martini V; Pizzi M; Trimarco V; Frezzato F; Marino F; Semenzato G; Trentin L; Baldari CT
    Cancer Res; 2015 Oct; 75(19):4153-63. PubMed ID: 26282174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR.
    Vegh Z; Kew RR; Gruber BL; Ghebrehiwet B
    Mol Immunol; 2006 Mar; 43(9):1402-7. PubMed ID: 16140380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets.
    Menning A; Höpken UE; Siegmund K; Lipp M; Hamann A; Huehn J
    Eur J Immunol; 2007 Jun; 37(6):1575-83. PubMed ID: 17474155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue.
    Kocks JR; Davalos-Misslitz AC; Hintzen G; Ohl L; Förster R
    J Exp Med; 2007 Apr; 204(4):723-34. PubMed ID: 17371929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of chemotactic networks by 'atypical' receptors.
    Comerford I; Litchfield W; Harata-Lee Y; Nibbs RJ; McColl SR
    Bioessays; 2007 Mar; 29(3):237-47. PubMed ID: 17295321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte migration to lymph nodes is maintained during homeostatic proliferation.
    Kodera M; Grailer JJ; Karalewitz AP; Subramanian H; Steeber DA
    Microsc Microanal; 2008 Jun; 14(3):211-24. PubMed ID: 18312727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.
    Vora KA; Nichols E; Porter G; Cui Y; Keohane CA; Hajdu R; Hale J; Neway W; Zaller D; Mandala S
    J Leukoc Biol; 2005 Aug; 78(2):471-80. PubMed ID: 15894589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The greater chemotactic network for lymphocyte trafficking: chemokines and beyond.
    Kim CH
    Curr Opin Hematol; 2005 Jul; 12(4):298-304. PubMed ID: 15928487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines in lymphocyte trafficking and intestinal immunity.
    Kunkel EJ; Campbell DJ; Butcher EC
    Microcirculation; 2003 Jun; 10(3-4):313-23. PubMed ID: 12851648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs.
    Veerman KM; Williams MJ; Uchimura K; Singer MS; Merzaban JS; Naus S; Carlow DA; Owen P; Rivera-Nieves J; Rosen SD; Ziltener HJ
    Nat Immunol; 2007 May; 8(5):532-9. PubMed ID: 17401367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.